Government anti-smoking campaign pulling no punches

The images are ones you wish you hadn't seen, that didn't exist, but they're real and they're going to be airing on a television channel near you for the next 12 weeks. They are part of the Department of Health and Human Services' (HHS) in-your-face anti-smoking campaign.

The imagery--which features people whose lives and bodies have become disfigured due to smoking, whether from lung or throat cancers, heart disease, or other diseases associated with smoking--is being brought to the public without apology.

"Tobacco continues to kill 443,000 Americans every year," said HHS Secretary Kathleen Sebelius. "And for every person who dies from smoking, at least two new young smokers take their place."

"As a nation we know what works," added Surgeon General Regina Benjamin. "So today we're going to educate the public with an aggressive media campaign."

"Our nation has reduced tobacco use by half since the first surgeon general's report [on smoking came out] in 1964," she added. "But since 2003 our progress has stalled. One in five adults in the U.S. continues to smoke."

Pulmonary issues are especially relevant in patients with both Hodgkin's and non-Hodgkin's lymphomas because effective existing treatments can often damage the lungs, whether through toxic chemotherapeutic drugs such as bleomycin, or through radiotherapy to the chest. Patients who are diagnosed and who smoke often have a more difficult time in recovery.

Source: Smokefree.gov

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap